Trade Mark Journal No.2026/027 3 July 2026
UK00004401424 12 June 2026 (5,42)
Concinnity Genetics
- Class 5
- Pharmaceutical and medical preparations; drugs for medical purposes; biological compounds or preparations; therapeutic preparations; biomarkers; genetic markers; RNA-based control systems, RNA synthesis inhibitors; pharmaceutical preparations for the prevention or treatment of tumours; pharmaceutical preparations for activating cellular function; cellular function activating agents for medical purposes; reconstituted cells for medical treatments; preparations for detecting genetic predispositions for medical purposes; preparations for detecting mutation in prion genes for medical purposes; nucleic acid sequences for medical purposes; nucleic recombinant acids for medical use; nucleic acid amplification reagents for medical use; RNA silencers; biological preparations for medical purposes; biological reagents for medical use; pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for use in tissue transplantation; tissues with defined cell ratios; pharmaceutical preparations relating to tissue transplants; tissue-regenerative pharmaceutical preparations; pharmaceutical preparations for the treatment of autoimmunity conditions, vascular diseases, lymphedema, inflammatory diseases, gastrointestinal diseases, neurological conditions, Musculo-skeletal diseases, orthopaedic conditions, dermatological conditions, ophthalmic conditions, respiratory diseases, pain, sensory disorders, genitourinary conditions, hormonal conditions, metabolic conditions, monogenic and polygenic diseases or age-related disorders.
- Class 42
- Research and development services; biological, scientific, clinical and medical research and development; drug discovery; drug development; clinical trials; research relating to genetics; research and development in the field of therapeutics; research and development services relating to bioinformatics; development of computer software, computing methods and algorithms; computer programming; database design; maintenance of database software; research and development in the fields of biotechnology, pharmaceuticals, diagnostic preparations, vaccines, medicines, molecular sciences, clinical trials or therapeutics; scientific research in the field of genetics and genetic engineering; genetic engineering services; genetic modification services; genetic mapping for scientific purposes; research in the field of gene therapy; scientific research in the field of genetics and genetic engineering; laboratory research in the field of gene expression; gene regulation platform services; chemical engineering; research and development in the field of cells; culturing of cells for scientific research purposes; biotechnology testing; services for assessing the efficiency of pharmaceuticals; analysis in the field of molecular biology; biological development services; biological cloning services; scientific laboratory services; laboratory testing and analysis services; biological research laboratory services; services of a chemical laboratory; laboratory analysis and research in the fields of bacteriology, gene expression or molecular biology; consultancy relating to research and development in the field of therapeutics; biochemical engineering services; clinical trials; blood analysis services for scientific research purposes; design and development of medical technology; design and development of diagnostic apparatus and equipment; electronic storage of medical records; computer aided diagnostic testing services; Platform as a Service [PaaS]; Software as a Service [Saas]; development of computer platforms; programming of software for information platforms on the Internet; software engineering; testing of computing methods, algorithms and software; design and development of computer software for use with medical technology; design and development of software for medical diagnostic purposes; design and development of systems for data input, output, processing, display and storage; hosting platforms on the Internet; design services relating to process systems for the biotechnology industry; provision of technical surveys; technical data analysis; database design and development; hosting of databases; rental of database management software; scientific research conducted using databases; installation and maintenance of database software; research in the field of artificial intelligence technology; software as a service featuring computer software platforms for artificial intelligence; analysis of human tissues for medical research; research and development services relating to the treatment of infectious diseases, viral diseases, parasitic diseases, autoimmunity conditions, vascular diseases, lymphedema, inflammatory diseases, gastrointestinal diseases, neurological conditions, Musculo-skeletal diseases, orthopaedic conditions, dermatological conditions, ophthalmic conditions, respiratory diseases, pain, sensory disorders, genitourinary conditions, hormonal conditions, metabolic conditions, monogenic diseases or age-related disorders; consultancy, information and advisory services relating to all of the aforesaid services.
Concinnity Genetics Ltd